# Bio-Techne to acquire Namocell

Bio-Techne Corporation reached an agreement to acquire Namocell, a provider of single cell sorting and dispensing platforms, to complement its Cell and Gene Therapy franchise.

- Type: Acquisition
- Announced: 2022-06-22
- Where: United States
- Status: announced
- Products: single cell sorting and dispensing platforms
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Bio-Techne Corporation](https://endata.com/companies/33492.md) (acquirer)
- [Namocell](https://endata.com/companies/63631.md) (target)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/bio-techne-to-acquire-namocell-301572556.html), 2022-06-22: "Namocell is very complementary to Bio-Techne's existing Cell and Gene Therapy franchise and we anticipate significant commercial synergies."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.